USFDA clears Solara Active's Visakhapatnam facility

USFDA clears Solara Active's Visakhapatnam facility

The plant is a new construction project with specialised manufacturing facilities for the active medicinal ingredient in ibuprofen as well as a multipurpose facility in phase 1

FPJ Web DeskUpdated: Monday, January 30, 2023, 01:53 PM IST
article-image
USFDA clears Solara Active's Visakhapatnam facility | Image: Solara Active (Representative)

The US Food and Drug Administration has cleared Solara Active Pharma Sciences Ltd's new multipurpose active pharmaceutical ingredient manufacturing facility at Visakhapatnam, Andhra Pradesh, with no observation, the company said in an exchange filing.

The inspection was carried out by the US drug regulator during Jan 23-26. The inspection established that the site is in an Acceptable State of Compliance and with Zero Form 483 inspectional observations from the agency.

The plant is a new construction project with specialised manufacturing facilities for the active medicinal ingredient in ibuprofen as well as a multipurpose facility in phase 1.

The institution has also begun verifying additional active pharmaceutical components in order to register in several globally regulated marketplaces.

RECENT STORIES

Amazon India, Flipkart Must Remove Products Infringing Reliance, Jio Trademarks: Delhi High Court

Amazon India, Flipkart Must Remove Products Infringing Reliance, Jio Trademarks: Delhi High Court

India, EU To Hold Next Round Of Free Trade Agreement Talks In September

India, EU To Hold Next Round Of Free Trade Agreement Talks In September

ICICI Prudential Life Q1 FY26 Profit Falls 21.8% QoQ, Premium Income Drops 48%

ICICI Prudential Life Q1 FY26 Profit Falls 21.8% QoQ, Premium Income Drops 48%

Gold Dips By ₹200 To ₹99,370 Per 10g, Silver Drops Sharply By ₹3,000 To Rs 1.12 Lakh/Kg

Gold Dips By ₹200 To ₹99,370 Per 10g, Silver Drops Sharply By ₹3,000 To Rs 1.12 Lakh/Kg

Exports Steady At USD 35.14 Bn In June, Trade Deficit Narrows To 4-Month Low Of USD 18.78 Bn

Exports Steady At USD 35.14 Bn In June, Trade Deficit Narrows To 4-Month Low Of USD 18.78 Bn